FORA Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Buy |
9,414
+4,389
| +87% | +$241K | 0.06% | 324 |
|
|
2025
Q1 | $355K | Buy |
5,025
+1,800
| +56% | +$127K | 0.04% | 380 |
|
|
2024
Q4 | $212K | Sell |
3,225
-22,174
| -87% | -$1.46M | 0.02% | 346 |
|
|
2024
Q3 | $1.79M | Buy |
25,399
+16,926
| +200% | +$1.19M | 0.21% | 141 |
|
|
2024
Q2 | $698K | Sell |
8,473
-19,350
| -70% | -$1.59M | 0.09% | 255 |
|
|
2024
Q1 | $2.43M | Buy |
27,823
+5,822
| +26% | +$508K | 0.2% | 135 |
|
|
2023
Q4 | $2.12M | Buy |
+22,001
| New | +$2.12M | 0.18% | 153 |
|
|
2023
Q1 | – | Sell |
-7,648
| Closed | -$791K | – | 527 |
|
|
2022
Q4 | $791K | Sell |
7,648
-847
| -10% | -$87.7K | 0.13% | 194 |
|
|
2022
Q3 | $720K | Buy |
+8,495
| New | +$720K | 0.14% | 203 |
|
|
2022
Q1 | – | Sell |
-3,920
| Closed | -$346K | – | 518 |
|
|
2021
Q4 | $346K | Buy |
+3,920
| New | +$346K | 0.13% | 205 |
|
|
2021
Q3 | – | Sell |
-16,030
| Closed | -$1.34M | – | 422 |
|
|
2021
Q2 | $1.34M | Buy |
+16,030
| New | +$1.34M | 0.25% | 102 |
|
|
2020
Q2 | – | Sell |
-11,805
| Closed | -$998K | – | 911 |
|
|
2020
Q1 | $998K | Buy |
+11,805
| New | +$998K | 0.22% | 121 |
|